Augustine et al developed a clinical score for identifying a patient with a bloodstream infection caused by an extended-spectrum beta-lactamase producing Enterobacteriaceae (ESBLE). This score can help decide whether or not a carbapenem should be started before susceptibility results are available. The authors are from the University of South Carolina.